celiprolol
ApprovedSmall molecule
celiprolol is one of 2 small molecule programs targeting Ehlers-Danlos syndrome, vascular type. It is currently in Approved.
1
Indications
3
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1 competitor in Ehlers-Danlos Syndrome, Vascular Type
#DrugCompanyPhaseTrials
1Avapro
SanofiApproved
celiprolol
AAssistance Publique - Hôpitaux de Paris
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Ehlers-Danlos syndrome, vascular type1 trial
Thoracic Surgery1 trial
Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery
Unknown status·—·Phase 2·NCT03752931·30 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for celiprolol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details